| Literature DB >> 29047382 |
Chao Wang1, Adam R Brentnall2, Jack Cuzick2, Elaine F Harkness3, D Gareth Evans4, Susan Astley3.
Abstract
BACKGROUND: The percentage of mammographic dense tissue (PD) is an important risk factor for breast cancer, and there is some evidence that texture features may further improve predictive ability. However, relatively little work has assessed or validated textural feature algorithms using raw full field digital mammograms (FFDM).Entities:
Keywords: Breast cancer; Breast density; Digital mammogram; Risk prediction; Texture
Mesh:
Year: 2017 PMID: 29047382 PMCID: PMC5648465 DOI: 10.1186/s13058-017-0906-6
Source DB: PubMed Journal: Breast Cancer Res ISSN: 1465-5411 Impact factor: 6.466
Demographics of the training set (cancers detected at first screen on entry to the PROCAS study) and validation set (cancers detected at a subsequent screen or between screening rounds)
| Training set | Validation set | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Controls | Cases |
| Controls | Cases |
| |||||
| N (%) | N (%) | N (%) | N (%) | |||||||
| Age at consent (years) | 0.9994 | 0.9997 | ||||||||
| <50 | 44 | (6) | 16 | (6) | 46 | (5) | 16 | (5) | ||
| 50–54 | 200 | (25) | 65 | (25) | 193 | (21) | 64 | (20) | ||
| 55–-59 | 150 | (19) | 51 | (19) | 164 | (18) | 58 | (18) | ||
| 60–64 | 172 | (22) | 57 | (22) | 286 | (31) | 96 | (30) | ||
| 65–69 | 166 | (21) | 57 | (22) | 195 | (21) | 67 | (21) | ||
| 70+ | 55 | (7) | 18 | (7) | 47 | (5) | 16 | (5) | ||
| HRT use | 0.2234 | 0.9646 | ||||||||
| Unknown | 11 | (1) | 7 | (3) | 22 | (2) | 6 | (2) | ||
| Never | 473 | (60) | 171 | (65) | 475 | (51) | 165 | (52) | ||
| Previous | 262 | (33) | 72 | (27) | 329 | (35) | 110 | (35) | ||
| Current | 41 | (5) | 14 | (5) | 105 | (11) | 36 | (11) | ||
| BMI (kg/m2) | 0.9797 | 0.9408 | ||||||||
| Unknown | - | - | - | 1 | (0) | |||||
| <25 | 241 | (31) | 80 | (30) | 335 | (36) | 117 | (37) | ||
| 25–29 | 289 | (37) | 96 | (36) | 341 | (37) | 113 | (36) | ||
| ≥30 | 257 | (33) | 88 | (33) | 255 | (27) | 86 | (27) | ||
| Menopausal status | 0.9914 | 0.9887 | ||||||||
| Unknown | 16 | (2) | 7 | (3) | 32 | (3) | 12 | (4) | ||
| Perimenopausal | 94 | (12) | 32 | (12) | 134 | (14) | 46 | (15) | ||
| Postmenopausal | 591 | (75) | 196 | (74) | 698 | (75) | 237 | (75) | ||
| Premenopausal | 86 | (11) | 29 | (11) | 67 | (7) | 22 | (7) | ||
| Ethnic origin | 0.0411 | 0.2229 | ||||||||
| Other/unknown | 38 | (5) | 22 | (8) | 81 | (9) | 35 | (11) | ||
| White | 749 | (95) | 242 | (92) | 850 | (91) | 282 | (89) | ||
| Parity | 0.8143 | 0.0351 | ||||||||
| Unknown | - | - | 1 | (0) | 4 | (1) | ||||
| Nulliparous | 97 | (12) | 34 | (13) | 90 | (10) | 44 | (14) | ||
| Parous | 690 | (88) | 230 | (87) | 840 | (90) | 269 | (85) | ||
| Tyrer-Cuzick (10-year risk, %) (median, Q1–Q3) | 2.73 | (2.19–3.60) | 2.82 | (2.29–3.88) | 0.0028 | 2.68 | (2.09–3.55) | 2.91 | (2.24–4.03) | <0.0001 |
| Volumetric PD (median, Q1–Q3) | 5.34 | (4.06–7.35) | 5.88 | (4.62–8.55) | 0.0003 | 4.73 | (3.50–6.92) | 5.31 | (3.79–7.57) | 0.0041 |
P values, from likelihood-ratio chi-square tests, indicate whether there are significant difference between cases and controls
HRT hormone replacement therapy, BMI body mass index, Q1 25th percentile, Q3 75th percentile, PD percent density
Spearman correlation coefficients between age, BMI, PD and texture features
| Age | BMI | Volumetric PD | Sum average 16 | Sum average 32 | Sum average 64 | SD | Coarseness | Contrast | |
|---|---|---|---|---|---|---|---|---|---|
| Age | 1 | ||||||||
| BMI | 0.03 | 1 | |||||||
| Volumetric PD | -0.14 | -0.57 | 1 | ||||||
| Sum average 16 | -0.19 | -0.35 | 0.63 | 1 | |||||
| Sum average 32 | -0.23 | -0.33 | 0.63 | 0.81 | 1 | ||||
| Sum average 64 | -0.18 | -0.23 | 0.54 | 0.74 | 0.88 | 1 | |||
| SD | -0.16 | -0.19 | 0.46 | 0.27 | 0.32 | 0.31 | 1 | ||
| Coarseness | -0.12 | -0.62 | 0.79 | 0.49 | 0.58 | 0.51 | 0.53 | 1 | |
| Contrast | 0.15 | 0.34 | -0.74 | -0.45 | -0.52 | -0.52 | -0.64 | -0.80 | 1 |
Sum average 16, 32 and 64 are texture feature sum average using images downsized by a factor of 16, 32 and 64
PD percent density, BMI body mass index, SD standard deviation
Univariate modelling results from the training dataset
| Parameter | Standardized odds ratio | 95% CI for odds ratio | χ2 |
| mC | 95% CI for mC |
|---|---|---|---|---|---|---|
| Coarseness | 1.22 | (1.06–1.41) | 7.28 | 6.98E-03 | 0.58 | (0.53– 0.62) |
| Contrast | 0.73 | (0.62–0.85) | 16.75 | 4.27E-05 | 0.40 | (0.36– 0.45) |
| SD | 1.32 | (1.13–1.54) | 13.11 | 2.94E-04 | 0.57 | (0.52– 0.61) |
| Sum average 16 | 1.52 | (1.31–1.77) | 31.26 | 2.25E-08 | 0.61 | (0.56– 0.65) |
| Sum average 32 | 1.52 | (1.31–1.77) | 31.75 | 1.75E-08 | 0.61 | (0.56– 0.66) |
| Sum average 64 | 1.48 | (1.28–1.71) | 29.07 | 6.98E-08 | 0.58 | (0.53– 0.63) |
| Volumetric PD | 1.36 | (1.18–1.57) | 18.05 | 2.16E-05 | 0.59 | (0.55– 0.64) |
Total number of observations (N) = 1051, including 264 cases and 787 controls. Standardized odds ratio is the change in odds for a standard deviation (in controls) increase in predictors, adjusted for age and body mass index. Sum average 16, 32 and 64 are the texture feature sum average using images downsized by a factor of 16, 32 and 64
PD percent density, CI confidence interval, mC matched concordance index, SD standard deviation
Fig. 1Matched concordance index (mC) for sum average at different image downsize factors, with bootstrap 95% confidence intervals (CI)
Fig. 2Comparison of mammograms (for presentation purpose processed images are shown) with two of the lowest (a) and highest (b) standardized risk scores. All mammograms have similar volumetric percent density (PD) around 10%. a Mammograms with low risk scores (-1.7 and -1.3, respectively). Volumetric PDs are 10.1% and 10.2%, respectively. b Mammograms with high risk scores (3.2 and 2.0, respectively). Volumetric PDs are 9.9% and 10.0%, respectively
Univariate modelling results using the validation dataset
| Parameter | Standardized odds ratio | 95% CI for odds ratio | χ2 |
| mC | 95% CI for mC |
|---|---|---|---|---|---|---|
| Risk score | 1.36 | (1.20–1.55) | 22.39 | 2.22E-06 | 0.58 | (0.54– 0.62) |
| Coarseness | 1.06 | (0.92–1.22) | 0.61 | 4.34E-01 | 0.50 | (0.46– 0.54) |
| Contrast | 0.87 | (0.76–0.99) | 4.33 | 3.75E-02 | 0.46 | (0.42– 0.50) |
| SD | 1.01 | (0.89–1.15) | 0.03 | 8.55E-01 | 0.50 | (0.45– 0.54) |
| Sum average 16 | 1.29 | (1.14–1.47) | 15.37 | 8.85E-05 | 0.58 | (0.54– 0.62) |
| Sum average 32 | 1.32 | (1.1–1.50) | 17.55 | 2.80E-05 | 0.58 | (0.53– 0.62) |
| Sum average 64 | 1.38 | (1.21–1.57) | 23.81 | 1.06E-06 | 0.59 | (0.55–0.63) |
| Volumetric PD | 1.27 | (1.11–1.46) | 11.84 | 5.80E-04 | 0.57 | (0.53– 0.61) |
Total number of observations (N) = 1248, including 317 cases and 931 controls. Standardized odds ratio is the change in odds for a standard deviation (in controls) increase in predictors, adjusted for age and body mass index. Sum average 16, 32 and 64 are the texture feature sum average using images downsized by a factor of 16, 32 and 64.
PD percent density, CI confidence interval, mC matched concordance index, SD standard deviation
Modelling results for screen-detected and interval cancer
| Risk score | Contrast | Sum average 16 | Sum average 32 | Sum average 64 | Volumetric PD | |
|---|---|---|---|---|---|---|
| Standardized OR for screen-detected cancer | 1.15 | 0.88 | 1.09 | 1.11 | 1.20 | 1.13 |
| (0.99–1.35) | (0.75–1.04) | (0.93–1.26) | (0.95–1.30) | (1.02–1.40) | (0.94–1.35) | |
| Standardized OR for interval cancer | 2.09 | 0.84 | 2.12 | 2.15 | 1.91 | 1.53 |
| (1.59–2.74) | (0.66–1.06) | (1.59–2.81) | (1.62–2.86) | (1.48–2.47) | (1.21–1.92) | |
| Δχ2 | 15.27 | 0.15 | 18.53 | 17.84 | 9.80 | 4.38 |
|
| 0.0001 | 0.70 | <0.0001 | <0.0001 | 0.002 | 0.036 |
Standardized odds ratio (OR) is the change in odds for a standard deviation (in controls) increase in image features; the 95% confidence intervals are in brackets. Sum average 16, 32 and 64 are the texture feature sum average using images downsized by a factor of 16, 32 and 64
The Δχ 2 and p values refer to likelihood-ratio tests on whether there is a significant difference between screen-detected and interval cancers (i.e. significance of interaction terms)
PD percent density